Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;75(1):36-44.
doi: 10.1111/j.1365-2125.2012.04375.x.

Risk: benefit of treating high blood pressure in older adults

Omar Mukhtar  1 , Stephen H D Jackson
Affiliations
Review

Risk: benefit of treating high blood pressure in older adults

Omar Mukhtar et al. Br J Clin Pharmacol. 2013 Jan.

Abstract

Older people (those aged 65 years or over) comprise over 15% of the UK's population and this cohort is growing. Whilst at greatest risk from systemic arterial hypertension (hypertension), its resultant end organ damage and clinically significant cardiovascular disease, this group was initially neglected in clinical trials and thereby denied treatment, with the lack of evidence cited as justification. However since the 1960s, when the first landmark trials in severe diastolic hypertension were published, there has been a progressive attempt to understand the pathophysiology of hypertension and to expand the evidence base for treatment in older adults. In contrast to the participants of the very first randomized trials who had a mean age of 51 years, the recent Hypertension in the Very Elderly Trial demonstrated significant mortality and morbidity benefits from the treatment of both mixed systolic and diastolic hypertension, as well as isolated systolic hypertension in octogenarians. This review highlights the progressive evidence base behind the relative risks and benefits of treating hypertension in older adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Absolute risk of stroke mortality in relation to blood pressure [38]. Reproduced with permission
Figure 2
Figure 2
Risk of adverse outcomes by age and blood pressure [33]. Reproduced with permission. <60 (formula image); 60–<70 (formula image); 70–<80 (formula image); ≥80 (formula image)
See this image and copyright information in PMC

References

    1. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens. 2006;24:413–422. - PubMed
    1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–313. - PubMed
    1. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007;50:1–13. - PubMed
    1. Nichols WW, O'Rourke MF. In: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 5th edn. London: Arnold; 2005.
    1. Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res. 2005;66:307–317. - PubMed

Substances